Literature DB >> 9032318

Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements.

P O Ilyinskii1, M A Simon, S C Czajak, A A Lackner, R C Desrosiers.   

Abstract

Rhesus monkeys (Macaca mulatta) were infected with five strains of simian immunodeficiency virus (SIV) derived from SIVmac239 containing deletions (delta) or substitutions (subst) in NF-kappaB and Sp1 binding sites. We have shown previously that mutations in these regions still allow efficient SIVmac replication in primary lymphoid cell cultures (P. O. Ilyinskii and R. C. Desrosiers, J. Virol. 70:3118-3126, 1996). Two animals were inoculated intravenously with each mutant strain of SIVmac239: delta NFkappaB, delta Sp1234, delta NFkappaB delta Sp1234, substSp12, and substSp1234. All but one of the infected animals showed an early spike in plasma antigenemia, maintained high virus burdens, and had significant changes in lymphoid tissues, and six died with AIDS within the first 60 weeks of infection. One of the animals infected with the SIV strain delta NFkappaB delta Sp1234 showed lower levels of plasma antigenemia and lower virus burdens; the other animal infected with this same mutant strain died with AIDS 17 weeks after inoculation. No consistent novel mutations or reversions were detected in proviral sequences derived from the animals infected with the deletion mutants and the substSp12 mutant by 20 weeks postinfection. Point-mutated sequences were partially deleted in both animals infected with the substSp1234 strain. These results indicate that the NF-kappaB and Sp1 binding sites are not essential for the induction of AIDS by SIVmac239. They also provide indirect evidence for the importance of a novel enhancer element in the U3 region of the SIVmac long terminal repeat that is located immediately upstream of the NF-kappaB binding site within the C-terminal region of the nef coding sequence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032318      PMCID: PMC191258     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Nuclear factors that bind two regions important to transcriptional activity of the simian immunodeficiency virus long terminal repeat.

Authors:  S Winandy; B Renjifo; Y Li; N Hopkins
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.

Authors:  E K Ross; A J Buckler-White; A B Rabson; G Englund; M A Martin
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

4.  Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.

Authors:  M C Hannibal; D M Markovitz; N Clark; G J Nabel
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.

Authors:  J W Maciaszek; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

6.  The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys.

Authors:  P O Ilyinskii; M D Daniel; M A Simon; A A Lackner; R C Desrosiers
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.

Authors:  D M Markovitz; M J Smith; J Hilfinger; M C Hannibal; B Petryniak; G J Nabel
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

8.  Progression to AIDS in the absence of a gene for vpr or vpx.

Authors:  J S Gibbs; A A Lackner; S M Lang; M A Simon; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.

Authors:  J M Hilfinger; N Clark; M Smith; K Robinson; D M Markovitz
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.

Authors:  N D Perkins; N L Edwards; C S Duckett; A B Agranoff; R M Schmid; G J Nabel
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  17 in total

1.  Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.

Authors:  C G Murphy; W T Lucas; R E Means; S Czajak; C L Hale; J D Lifson; A Kaur; R P Johnson; D M Knipe; R C Desrosiers
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.

Authors:  Welkin E Johnson; Jeffrey D Lifson; Sabine M Lang; R Paul Johnson; Ronald C Desrosiers
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Vaccination with attenuated simian immunodeficiency virus by DNA inoculation.

Authors:  S J Kent; C J Dale; S Preiss; J Mills; D Campagna; D F Purcell
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries.

Authors:  Tyler A Johnson; Johann Sohn; Yvette M Vaske; Kimberly N White; Tanya L Cohen; Helene C Vervoort; Karen Tenney; Frederick A Valeriote; Leonard F Bjeldanes; Phillip Crews
Journal:  Bioorg Med Chem       Date:  2012-05-24       Impact factor: 3.641

5.  Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239.

Authors:  L Alexander; L Denekamp; S Czajak; R C Desrosiers
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements.

Authors:  S Pöhlmann; S Flöss; P O Ilyinskii; T Stamminger; F Kirchhoff
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.

Authors:  Philippe Blancou; Nicole Chenciner; Raphaël Ho Tsong Fang; Valérie Monceaux; Marie-Christine Cumont; Denise Guétard; Bruno Hurtrel; Simon Wain-Hobson
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys.

Authors:  Louis Alexander; Petr O Illyinskii; Sabine M Lang; Robert E Means; Jeffrey Lifson; Keith Mansfield; Ronald C Desrosiers
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.

Authors:  M C Estable; B Bell; M Hirst; I Sadowski
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.